ChromaDex (NASDAQ:CDXC) PT Raised to $6.00

ChromaDex (NASDAQ:CDXC – Get Free Report) had its price objective hoisted by stock analysts at Roth Mkm from $4.25 to $6.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s price objective points to a potential upside of 44.58% […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Roth Mkm ,Chromadex Corporation ,Topco Ltd ,Vanguard Group Inc ,Jpmorgan Chase Co ,Cambridge Investment Research Advisors Inc ,Renaissance Technologies ,Nasdaq ,Get Free Report ,Investment Research Advisors ,Xidex Corporation ,Analytical Reference Standards ,Chromadex Daily ,